Home » Media

Media

International Program Spotlights the BRICs at the 2013 BIO International Convention
With one-third of all attendees international, the 2013 BIO International Convention will host a wide range of programming focused on new opportunities...
Farmers Increasingly Favor Biotech Crops
The ISAAA report, Global Status of Commercialized Biotech/GM Crops: 2012, says a record 17.3 million farmers in 28 countries are growing biotech crops on 420...

Press Releases

President Clinton Proclaims January 2000 National Biotechnology Month
Jan 21 2000
WASHINGTON, D.C. (Jan. 21, 1999) Not too long ago, the idea of treating the root causes of diseases was just that, an idea. And so was the prospect of feeding...
Biotech Starts 2000 With A Bang As Recent Gains Rival Internet Stocks
Jan 20 2000
CEO & Investor Conference To Showcase Industry To New Investors WASHINGTON, D.C. (January 20, 2000) Recent gains inbiotechnology stocks have rivaled the...
BIO’s First TV Ad on the Air
Jan 18 2000
WASHINGTON, D.C. (January 14, 2000) A BIO-sponsored television ad will begin running Jan. 17 on cable and news talk shows throughout the Washington...
Biotech Drug Approvals Top 90 With Hundreds More In Late-Stage Clinical Trials
Jan 18 2000
WASHINGTON, D.C. (Jan. 18, 2000) Another 22biotechnology drugs, vaccines and new indications for existing medicines were approved by the U.S. Food and Drug...
Countdown to BIO 2000 Press Can Register Now!
Jan 11 2000
Washington, D.C. (January 11, 2000) The Biotechnology Industry Organization (BIO) will host its 14th International Biotechnology Meeting and Exhibition two...
Judah Folkman, Jurgen Drews Keynote Speakers Conference
Dec 20 1999
WASHINGTON, D.C. (Dec. 20, 1999) -- Dr. Judah Folkman, who discovered the process of tumor angiogenesis, and Dr. Jurgen Drews, former president of global...
BIO Puts Forth Gene Therapy Oversight Proposal
Dec 7 1999
WASHINGTON, D.C. (Dec. 7, 1999) -- The Biotechnology Industry Organization (BIO) will present alternatives to proposed guidelines for reporting adverse patient...
The Passing of Bob Swanson
Dec 6 1999
(Carl Feldbaum, president of BIO, today issued the following statement upon the death of Bob Swanson, co-founder of Genentech): Washington, D.C. (December 6,...
Sound Evidence, Not Politics or Trade Discrimination Should Be Used to Assess Biotech Foods
Nov 24 1999
(Carl B. Feldbaum, president of the Biotechnology Industry Organization, issued the following statement prior to the start of the World Trade Organization's...
Senate Declares January 2000 National Biotechnology Month
Nov 23 1999
See Senate Resolution 200 below WASHINGTON, D.C. (Nov. 23, 1999) -- The Biotechnology Industry Organization (BIO) applauds the U.S. Senate for its adoption of...


Biotechnology News

Idera Announces Presentation at AAD Annual Meeting Demonstrating Toll-like Receptor Antagonists Normalize Expression of Inflammatory Genes in Psoriasis Model
March 2, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera presented new data showing that its selective Toll-like receptor antagonists normalized the gene expression of important cytokines...

Oral Apremilast Achieves Statistical Significance for the Primary Endpoint of PASI-75 in the First Phase III Study (ESTEEM 1) in Patients with Psoriasis
March 2, 2013

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today presented the results from ESTEEM 1, the Company...

KYTHERA Biopharmaceuticals, Inc. Announces Positive Interim Results from Open-Label Study of ATX-101 in the Reduction of Unwanted Submental Fat (SMF) or “Double Chin”
March 2, 2013

MIAMI BEACH, Fla.--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced positive interim results from a Phase IIIb, multi-center, open-label...

‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says the Committee on Fair Drug Pricing (a.k.a. FAIR)
March 1, 2013

SAN FRANCISCO--(BUSINESS WIRE)--‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says Committee on Fair Drug Pricing (a.k.a. FAIR)-Coalition of...

Gilead Sciences to Present at the Cowen & Company 33rd Annual Health Care Conference on Monday, March 4
March 1, 2013

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Cowen and Company 33rd...